Last reviewed · How we verify
suganon tab 5mg
suganon tab 5mg is a Small molecule drug developed by Yonsei University. It is currently FDA-approved.
Suganon Tab 5mg is used to treat conditions such as Type 2 Diabetes Mellitus and Hepatitis B with significant hepatic fibrosis. However, there is limited information available on Suganon Tab 5mg, as it is not mentioned in the provided facts, and the only information available is related to Suganon Tab 15mg and evogliptin.
At a glance
| Generic name | suganon tab 5mg |
|---|---|
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes (PHASE4)
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases (PHASE4)
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes (PHASE4)
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- suganon tab 5mg CI brief — competitive landscape report
- suganon tab 5mg updates RSS · CI watch RSS
- Yonsei University portfolio CI
Frequently asked questions about suganon tab 5mg
What is suganon tab 5mg?
Who makes suganon tab 5mg?
What development phase is suganon tab 5mg in?
Related
- Manufacturer: Yonsei University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing